The product performance of many top fund managers has flourished, and the performance of some equity funds has been impressive
On November 26, Capital Bank learned that halfway through the fourth quarter of 2021. Looking back at the market performance since October, it can be seen that in the A-share market, new energy, cyclical stocks, and big consumers have taken turns in the performance of the A-share market. The phased style characteristics are obvious and the rotation speed is fast. Against this backdrop, some fund managers have seized market opportunities, and yields have risen. According to Choice data, as of November 25, 2021, there were 290 equity funds (hybrid, stock, other) with poor performance in the first three quarters on the market, and their earnings during the year after a rebound in performance in the fourth quarter
The market will enter the stage of "profit driven + valuation matching".
In the third quarter, the A-share market experienced an initial rapid rise and fell into shock. After the growth and blue-chip valuation diverged to a certain extent, the market style also showed a "rebalancing" trend. Growth assets such as medicine and biology, which had a large increase in the previous period, made a significant correction, while the pro-cyclical sector had significant excess returns under the expectation of economic recovery. Fund managers' investment emphasizes "conforming to the trend". A number of star fund managers said in the three quarterly reports that although they still maintained the allocation of core assets such as science and technology and medicine, they appropriately increased their holdings of undervalued products such as large manufacturing and finance in the portfolio. In the long run, we are still more optimistic about the sustainable value creation ability of high-quality enterprises. Not
The third quarterly report shows that institutions have formed groups for pharmaceutical technology stocks
As of October 21, nearly 180 listed companies have disclosed their three-quarter reports, and trends in institutional holdings represented by public funds, social security funds, and qualified foreign institutional investors (QFII) have surfaced. According to the data, high-performing individual stocks in popular industries such as technology and pharmaceuticals are still the target of groups of various institutions. Public funds showed 81 shares by the end of the third quarter, and public funds appeared on the list of the top ten tradable shareholders of 81 stocks. Shareholding trends showed that holdings were reduced by 63 and increased by 18. Judging from the number of participating public funds, the number of individual stocks held by groups of 3 or more funds reached 39 at the end of the third quarter. Among them, Yamakawa medicine appeared
Swap 6124 points to double the yield of nearly 40% of active equity funds in 13 years
Active equity funds with a yield of more than 200% since the Shanghai Composite Index hit a record high of 6124 points on 2007/10/16. On 2007/10/16, the Shanghai Composite Index recorded 6124 points, setting a record high. After 13 years, the index hovered around 3,300 points, but during the same period, the net worth of a number of funds rose steadily and achieved outstanding performance. The yield of nearly 40% of active equity funds doubled, reaching a high of 359.51%. Industry insiders said that the reversal of the active equity fund market created excellent long-term absolute returns, confirmed the concept of creating investment value through in-depth research, and fully reflected the price of public equity funds
BUY BUY BUY! There is a big competition for public funds to “buy themselves”. This type of fund is the most popular; what employees buy is the best?
Fund company employees often need to know more about their company's products than ordinary investors. To a certain extent, employees' self-purchasing behavior reflects the practitioners' real approval of the products. You might as well look at what the fund company's employees have bought through data. According to statistics, among active equity funds (excluding pension funds and strategic placement funds), employees of 20 fund products purchased more than 17 million yuan. Among them, Fuguo Tianhui Selected Growth was held by its own employees as high as 53.97 million yuan, ranking first; while Jingshun Great Wall Xinxing Growth was held by employees with 41.64 million yuan, ranking second; Dongfanghong, Shanghai, Hong Kong, and Shenzhen were owned by employees
Funds choose funds prefer “top students”
The first batch of Funds-in-Fund (FOF) three-quarter reports were released yesterday, and the products of high-performing fund managers are favored. Judging from the performance of the technology sector in the third quarter, the performance of the technology sector contributed excess revenue to many FOF products, and some FOF products achieved increased performance through the Science and Technology Innovation Board by opening new funds. Many fund managers said they are optimistic about investment opportunities in technology funds and growth funds. Data that favors high-performing funds shows that in the first batch of FOFs to disclose quarterly reports, quite a few well-known funds were favored by many external FOF products. For example, funds managed by China-Europe funds Zhou Weiwen and Zhou Yingbo are held by many external FOFs, and those managed by Zhou Weiwen